129 related articles for article (PubMed ID: 19664616)
1. Evaluation of amphetamine-induced hyperlocomotion and catalepsy following long-acting risperidone administration in rats.
Marchese G; Casu G; Casti P; Spada GP; Pani L
Eur J Pharmacol; 2009 Oct; 620(1-3):36-41. PubMed ID: 19664616
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
3. Clinical review of a long-acting, injectable formulation of risperidone.
Knox ED; Stimmel GL
Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763
[TBL] [Abstract][Full Text] [Related]
4. Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
Megens AA; Niemegeers CJ; Awouters FH
J Pharmacol Exp Ther; 1992 Jan; 260(1):160-7. PubMed ID: 1370539
[TBL] [Abstract][Full Text] [Related]
5. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
[TBL] [Abstract][Full Text] [Related]
6. Cinnarizine has an atypical antipsychotic profile in animal models of psychosis.
Dall'Igna OP; Tort AB; Souza DO; Lara DR
J Psychopharmacol; 2005 Jul; 19(4):342-6. PubMed ID: 15982988
[TBL] [Abstract][Full Text] [Related]
7. [Catalepsy and hyperkinesis induced by the chronic administration of a tetrapeptide into the rat neostriatum].
Iakimovskiĭ AF
Fiziol Zh SSSR Im I M Sechenova; 1991 Jan; 77(1):22-8. PubMed ID: 1652493
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA
Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute or chronic administration of risperidone on motor and sexual behavior of male rats.
Drago F; Contarino A; Marino R; Anzallo C; Valerio C; Rampello L; Raffaele R; Scapagnini U
Pharmacol Res; 1997 Jan; 35(1):17-25. PubMed ID: 9149311
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic risperidone treatment on the striatal protein profiles in rats.
O'Brien E; Dedova I; Duffy L; Cordwell S; Karl T; Matsumoto I
Brain Res; 2006 Oct; 1113(1):24-32. PubMed ID: 16938284
[TBL] [Abstract][Full Text] [Related]
11. DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice.
Lautar SL; Rojas C; Slusher BS; Wozniak KM; Wu Y; Thomas AG; Waldon D; Li W; Ferraris D; Belyakov S
Brain Res; 2005 Jun; 1048(1-2):177-84. PubMed ID: 15925329
[TBL] [Abstract][Full Text] [Related]
12. Chronic administration of quetiapine alleviates the anxiety-like behavioural changes induced by a neurotoxic regimen of dl-amphetamine in rats.
He J; Xu H; Yang Y; Zhang X; Li XM
Behav Brain Res; 2005 May; 160(1):178-87. PubMed ID: 15836913
[TBL] [Abstract][Full Text] [Related]
13. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
Ali O; Haleem DJ; Saify ZS; Kamil N; Obaid R; Ahmed SW
Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
[TBL] [Abstract][Full Text] [Related]
14. Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
Boules M; McMahon B; Wang R; Warrington L; Stewart J; Yerbury S; Fauq A; McCormick D; Richelson E
Brain Res; 2003 Oct; 987(1):39-48. PubMed ID: 14499944
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
Gruber SH; Nomikos GG; Mathé AA
Eur Neuropsychopharmacol; 2006 Dec; 16(8):592-600. PubMed ID: 16524702
[TBL] [Abstract][Full Text] [Related]
16. Effects of risperidone on locomotor activity and spatial memory in rats with hippocampal damage.
Bardgett ME; Baum KT; O'Connell SM; Lee NM; Hon JC
Neuropharmacology; 2006 Dec; 51(7-8):1156-62. PubMed ID: 16934300
[TBL] [Abstract][Full Text] [Related]
17. Use of long-acting risperidone.
Parker G
Psychiatr Serv; 2005 Jan; 56(1):105-6; author reply 106-7. PubMed ID: 15637203
[No Abstract] [Full Text] [Related]
18. 1192U90 in animal tests that predict antipsychotic efficacy, anxiolysis, and extrapyramidal side effects.
Rigdon GC; Norman MH; Cooper BR; Howard JL; Boncek VM; Faison WL; Nanry KP; Pollard GT
Neuropsychopharmacology; 1996 Sep; 15(3):231-42. PubMed ID: 8873106
[TBL] [Abstract][Full Text] [Related]
19. The effect of chronic antipsychotic treatment on sexual behaviour, hormones and organ size in the male rat.
Zhang X; Zhang Z; Cheng W; Mou X; Reynolds GP
J Psychopharmacol; 2007 Jun; 21(4):428-34. PubMed ID: 17050660
[TBL] [Abstract][Full Text] [Related]
20. Effects of apomorphine and amphetamine in rats with a permanent catalepsy induced by diencephalic lesion.
Boissier JR; Etevenon P; Piarroux MC; Simon P
Res Commun Chem Pathol Pharmacol; 1971 Nov; 2(6):829-36. PubMed ID: 5170595
[No Abstract] [Full Text] [Related]
[Next] [New Search]
